Medicare Enrolled
Dr. Mark Aldous, M.D.
Gastroenterology · Concord, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Aldous from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aldous?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Aldous
Dr. Mark Aldous is a gastroenterology specialist in Concord, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Aldous performed 763 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Aldous received a total of $12,240 from 52 pharmaceutical and/or device companies across 669 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Aldous is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 33% volume in NC
$12,240 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗763
Medicare services
Top 33% in NC for gastroenterology
Not available
Unique patients (not deduplicated)
$96
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
177 | $89 | $200 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
110 | $68 | $772 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
87 | $54 | $142 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
82 | $199 | $1,181 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
55 | $114 | $265 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
41 | $98 | $227 |
| Dilation of esophagus | 33 | $31 | $357 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
27 | $99 | $1,050 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
25 | $176 | $879 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
24 | $60 | $123 |
| Upper endoscopy (EGD) A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope. |
23 | $68 | $671 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
21 | $39 | $69 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
19 | $70 | $175 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
15 | $133 | $879 |
| Balloon dilation of esophagus, stomach, or upper small bowel, less than 3.0 cm A procedure using a flexible endoscope to widen a narrowed section of the esophagus, stomach, or upper small bowel with a balloon that is less than 3.0 cm in length. |
12 | $98 | $458 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
12 | $176 | $879 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$12,240
Total received (2018-2024)
Avg $1,749/year across 7 years
Top 14% in NC for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
669
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,001
2023
$2,705
2022
$2,097
2021
$1,936
2020
$874
2019
$1,224
2018
$1,403
Payments by company (2024)
ABBVIE INC.
$742
Gilead Sciences, Inc.
$263
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$146
GENZYME CORPORATION
$111
Madrigal Pharmaceuticals
$91
Alnylam Pharmaceuticals Inc.
$89
Takeda Pharmaceuticals U.S.A., Inc.
$84
Regeneron Healthcare Solutions, Inc.
$57
Medtronic, Inc.
$50
Intercept Pharmaceuticals, Inc.
$46
IRONWOOD PHARMACEUTICALS, INC
$41
Organon Llc
$38
Fresenius Kabi USA, LLC
$35
Janssen Biotech, Inc.
$33
QOL Medical, LLC
$30
Celltrion USA Inc.
$21
Lilly USA, LLC
$20
Sandoz Inc.
$20
Novo Nordisk Inc
$19
Boston Scientific Corporation
$17
Merck Sharp & Dohme LLC
$17
PFIZER INC.
$15
Teleflex LLC
$15
Top 3 companies account for 57.5% of 2024 payments
All-time payments by company (2018-2024) ›
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,719
ABBVIE INC.
$971
Gilead Sciences, Inc.
$941
Medtronic, Inc.
$894
AbbVie Inc.
$870
Janssen Biotech, Inc.
$783
Takeda Pharmaceuticals U.S.A., Inc.
$717
Alnylam Pharmaceuticals Inc.
$551
AbbVie, Inc.
$455
PFIZER INC.
$396
Amgen Inc.
$318
Ferring Pharmaceuticals Inc.
$317
UCB, Inc.
$314
Intercept Pharmaceuticals, Inc.
$313
GENZYME CORPORATION
$212
Celgene Corporation
$203
Ironwood Pharmaceuticals, Inc
$183
QOL Medical, LLC
$176
Nestle HealthCare Nutrition Inc.
$171
Regeneron Healthcare Solutions, Inc.
$144
Merck Sharp & Dohme Corporation
$130
Shire North American Group Inc
$120
RedHill Biopharma Inc.
$91
Madrigal Pharmaceuticals
$91
Ardelyx, Inc.
$86
Merck Sharp & Dohme LLC
$82
Braintree Laboratories, Inc.
$79
INTRA-SANA LABORATORIES
$71
INTERCEPT PHARMACEUTICALS, INC.
$70
Daiichi Sankyo Inc.
$62
Synergy Pharmaceuticals Inc
$62
IRONWOOD PHARMACEUTICALS, INC
$57
Boston Scientific Corporation
$48
Romark Laboratories, LC
$43
Celltrion USA Inc.
$42
Organon LLC
$38
Organon Llc
$38
Evoke Pharma, Inc.
$37
EVOKE PHARMA, INC.
$37
Concordia Pharmaceuticals Inc.
$36
VIVUS LLC
$35
Fresenius Kabi USA, LLC
$35
Ethicon US, LLC
$34
NESTLE HEALTHCARE NUTRITION INC.
$34
Lilly USA, LLC
$20
Sandoz Inc.
$20
Novo Nordisk Inc
$19
Alfasigma USA, Inc.
$17
Covidien LP
$16
Teleflex LLC
$15
Allergan, Inc.
$14
Alcon Laboratories Inc
$12
Top 3 companies account for 29.7% of all-time payments
Associated products mentioned in payments ›
AMJEVITA · APRISO · AVSOLA · Alinia · Alinia Tablets 500mg 30 count bottle · Amitiza · Bravo · CIMZIA · CLENPIQ · CREON · Cimzia · Creon · DIFICID · DUPIXENT · Donnatal · ENTYVIO · EXALT Model D · Entyvio · GATTEX · GIMOTI · GIVLAARI · HADLIMA · HUMIRA · HYRIMOZ · Humira · IBSRELA · IDACIO · INFLECTRA · INJECTAFER · INTERSTIM · LINX Reflux Management System · LINZESS · LenSx · Linzess · MAVYRET · MOTOFEN · Mavyret · Motegrity · Movantik · OCALIVA · OMVOH · PLENVU · PREPOPIK · QSYMIA · Qsymia · REBYOTA · RELTONE 200 MG · RENFLEXIS · RESMETIROM · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUFLAVE · SUPREP · SUPREP BOWEL PREP · SUTAB · Sucraid · TRULANCE · Talicia · Trulance · UCERIS TABLETS · UROLIFT · VIBERZI · Wegovy · XELJANZ · XIFAXAN · YUFLYMA · ZENPEP · ZEPATIER · ZEPOSIA · ZYMFENTRA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Gastroenterologists in nearby ZIP areas
65
County median income
$86,084
Nearest hospital to ZIP centroid (approximate)
CAROLINAS MEDICAL CENTER-NORTHEAST
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Aldous is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Aldous experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Aldous performed 177 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Aldous receive payments from pharmaceutical companies?
Yes. Dr. Aldous received a total of $12,240 from 52 companies across 669 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Aldous's costs compare to other gastroenterologists in Concord?
Dr. Aldous's average Medicare payment per service is $96. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Aldous) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Concord
Browse gastroenterologists in Concord ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in NC
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in NC
Which NC gastroenterologists receive the most from drug and device companies.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology